Sort   by:  
 Page size 
GenomicsGut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
There is a growing appreciation of the role of the microbiome in cancer, and evidence in pre-clinical models that the gut microbiome may modulate responses to immune checkpoint blockade though this has not been well-characterized in patients. We analyzed the oral (n=86)and gut (n=43) 16S microbiome ...
EGAS00001002698 | EGA
Genomicsena-DATASET-MDACC-02-02-2018-10:54:47:473-560 - samples
The oral and gut microbiomes of melanoma patients were characterized before the initiation of ant-PD1 immunotherapy, and compared to treatment response. Validation studies were performed in germ-free mice using stool from patients who responded/did not respond to ant-PD1 immunotherapy. All baseline...
EGAD00001003943 | EGA
UnknownDurable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma.
Not available
S-EPMC11415805 | biostudies-literature
UnknownFDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
Not available
S-EPMC11938238 | biostudies-literature
UnknownLymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma.
Not available
S-EPMC12360205 | biostudies-literature
UnknownPulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
Not available
S-EPMC12061388 | biostudies-literature
UnknownNeoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
Not available
S-EPMC9618687 | biostudies-literature
Genomicsena-DATASET-MDACC-31-10-2017-21:58:14:730-1118 - samples
This dataset contains WES data (.bam files) and associated phenotype information from 10 patients included in our microbiome study who went on to anti PD-1 immunotherapy for the treatment of metastatic melanoma at the University of Texas MD Anderson Cancer Center. Both tumor and matching germ line n...
EGAD00001003797 | EGA
GenomicsThis committee is composed on individuals who have access to the data corresponding to this project: Gut microbiome modulates response to anti PD-1 immunotherapy in melanoma patients
Data Access Committee EGAC00001000758
EGAC00001000758 | EGA
UnknownPhase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.
Not available
S-EPMC12434394 | biostudies-literature
Sort   by:  
 Page size